1222. Deputy Ken O'Flynn asked the Minister for Health if her Department has assessed the economic and workforce impact associated with long-term lyme disease illness, including inability to work and disability-related impacts; and if she will make a statement on the matter. [39066/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Ken O'Flynn under the heading Disease Management.
40 questions match, newest first.
778. Deputy Ken O'Flynn asked the Minister for Health the proportion of cases of type 2 diabetes and cardiovascular disease that are attributable to obesity in Ireland; the annual treatment cost to the HSE for these obesity-related conditions; the estimated share of total healthcare expenditure linked to obesity-related disease; and if she will make a statement on the matter. [28095/26]
779. Deputy Ken O'Flynn asked the Minister for Health the estimated annual cost to the HSE of treating obesity and obesity-related conditions between 2020 to date; the breakdown of this cost, across hospital care, primary care, pharmaceuticals and community services, in tabular form; and if she will make a statement on the matter. [28096/26]
780. Deputy Ken O'Flynn asked the Minister for Health if her Department or the HSE has projected the cost to the health service over the next ten years if obesity prevalence continues to rise; and if she will make a statement on the matter. [28097/26]
783. Deputy Ken O'Flynn asked the Minister for Health the regional prevalence of obesity in Ireland; the regions with the highest hospital admission rates for obesity-related illness; the steps being taken to address health inequalities linked to obesity; and if she will make a statement on the matter. [28100/26]
919. Deputy Ken O'Flynn asked the Minister for Health if the Oversight Implementation Group for the National Rare Disease Strategy has been established, given that the strategy was published in August 2025; and if she will make a statement on the matter. [16945/26]
1029. Deputy Ken O'Flynn asked the Minister for Health whether her Department has assessed whether the absence of programme-level expenditure analysis for high-prevalence chronic conditions, including chronic pain, is consistent with public financial management standards and performance-based budgeting principles; whether any review of this matter has been undertaken since 2020; and if she will make a statement on th…
626. Deputy Ken O'Flynn asked the Minister for Health further to the reply to Parliamentary Questions Nos. 2312 to 2316 of 13 January 2026, whether her Department holds the HSE tender evaluation summary, cost-effectiveness analysis, and decision documentation underpinning the decision not to procure enhanced influenza vaccines for the 2025 to 2026 season; and if so, to state whether she will publish the non-commercia…
2312. Deputy Ken O'Flynn asked the Minister for Health whether her Department considered the procurement of an enhanced influenza vaccine for the 2025–2026 flu season; the advice received from the HSE and the National Immunisation Advisory Committee in this regard; the evidence base relied upon in deciding not to procure such a vaccine; and if she will publish the clinical, cost-effectiveness, and policy assessments …
2313. Deputy Ken O'Flynn asked the Minister for Health the estimated additional cost, in absolute and per-patient terms, of procuring an enhanced influenza vaccine for persons aged 65 years and over for the 2025–2026 flu season; how this cost was weighed against projected hospital admissions, bed-day usage, and emergency department demand associated with influenza; and whether a formal cost-benefit or health-impact a…
2314. Deputy Ken O'Flynn asked the Minister for Health whether her Department assessed the potential impact of not procuring an enhanced influenza vaccine on winter infection rates, hospital overcrowding, and emergency department capacity during the 2025 Christmas period; and if so, to outline the findings of that assessment and the mitigation measures put in place. [75077/25]
2316. Deputy Ken O'Flynn asked the Minister for Health whether budgetary constraints influenced the decision not to procure an enhanced influenza vaccine for the current season; whether a specific budget line was sought or refused for that purpose; and how influenza vaccination policy is prioritised within overall winter-planning and hospital-capacity frameworks. [75079/25]
945. Deputy Ken O'Flynn asked the Minister for Health the public-health risk assessments completed since 1 January 2020 concerning communicable-disease risks among persons arriving into the State, including tuberculosis, measles, polio and hepatitis; and to provide the date of each assessment, the body or officer that carried out each assessment, the findings, the actions taken, and any guidance issued by her Departm…
626. Deputy Ken O'Flynn asked the Minister for Health if any recommendation has been made by the Chief Medical Officer or the Health Protection Surveillance Centre to reintroduce or expand health screening protocols for persons entering or residing in the State. [64903/25]
627. Deputy Ken O'Flynn asked the Minister for Health the screening, vaccination or health evaluation measures that were in place for new arrivals to the State before 2020, the date these measures ceased, and the reason the Department ended or amended those protocols. [64904/25]